Mode
Text Size
Log in / Sign up

Higher serum free fatty acid levels associated with worse 3-month prognosis after acute ischemic strokeHigher blood fat levels linked to worse recovery after stroke in Chinese study

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note: Elevated serum FFA associated with worse stroke prognosis in observational analysis.

This post hoc analysis of the INSPIRES randomized controlled trial examined the association between baseline serum free fatty acid (FFA) concentration and 3-month prognosis in 5,813 patients with acute ischemic stroke from 222 hospitals in China. FFA levels were measured from fasting venous blood samples collected within 24 hours after randomization, and patients were divided into quartile groups for comparison (Q4 vs. Q1, Q3 vs. Q1).

Higher baseline FFA levels were associated with increased risk of new stroke at 3 months (HR 1.85, 95% CI 1.41 to 2.43 for Q4 vs. Q1). Elevated FFA was also associated with higher risk of poor functional outcome (RR 1.66 for Q3 vs. Q1, 95% CI 1.19 to 2.32; RR 1.73 for Q4 vs. Q1, 95% CI 1.37 to 2.16). Similar positive associations were observed for composite vascular events, ischemic stroke, and all-cause mortality, though specific effect sizes and absolute numbers were not reported.

Safety and tolerability data were not reported in this analysis. The primary limitation is that this was a post hoc analysis, which can only show association rather than establish causation. The analysis did not report absolute event rates, making it difficult to assess clinical magnitude. Funding and conflicts of interest were not reported.

For clinical practice, this analysis suggests serum FFA may be a prognostic biomarker in acute ischemic stroke, but the evidence remains observational. The findings should not be interpreted as supporting causal relationships or specific therapeutic interventions targeting FFA levels. Further prospective studies are needed to validate these associations and explore potential mechanisms.

Researchers looked at data from a large clinical trial in China to see if a type of fat in the blood, called free fatty acids (FFA), was linked to how well people recover after a stroke. They studied 5,813 patients who had just had an ischemic stroke, measuring their FFA levels within 24 hours. The patients were from 222 hospitals, with a median age of 65, and about 36% were women.

The study found that patients with the highest levels of FFA had about an 85% higher risk of having another stroke within three months compared to those with the lowest levels. They also had a 66-73% higher risk of having a poor functional outcome, meaning more difficulty with daily activities. The study did not report on specific safety issues or side effects related to FFA levels.

It is important to be careful with these results. This was a 'post hoc' analysis, which means the researchers looked back at data that was already collected for a different purpose. It shows a link or association, but it does not prove that high FFA levels cause worse outcomes after a stroke. The study also did not report the actual number of events, so we don't know how common these outcomes were. Readers should see this as an early finding that helps scientists ask new questions, not as a reason to change their own medical care.

What this means for you:
A study found a link between higher blood fat levels and worse recovery after stroke, but more research is needed to understand why.

Study Details

Study typeRct
Sample sizen = 5,813
EvidenceLevel 2
Follow-up780.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Free fatty acid (FFA) serves as an important link between metabolic risk factors and atherosclerotic vascular disease. In this post hoc analysis of the Intensive Statin and Antiplatelet Therapy for Acute High Risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial, we aimed to investigate whether serum FFA concentration was associated with prognosis of acute ischemic stroke. METHODS: Data was obtained from the INSPIRES trial, which was a randomized, double-blind, placebo-controlled, multicenter two-by-two factorial trial at 222 hospitals in China. Fasting venous blood samples were collected from all subjects within 24 hours after randomization. Enrolled patients were divided into 4 groups according to the FFA quartiles. RESULTS: A total of 5813 participants were included, with the median age of 65 years, and 35.9% were women. The median FFA level was 0.45 (interquartile range, 0.31-0.61) mmol/L. After adjusting for potential covariates, elevated FFA level was associated with higher risk of new stroke at 3 months (Q4 vs. Q1: HR 1.85, 95% CI 1.41 to 2.43) and poor functional outcome (Q3 vs. Q1: RR 1.66, 95% CI 1.19 to 2.32; Q4 vs. Q1: RR 1.73, 95% CI 1.37 to 2.16). FFA as a continuous variable was associated with a new stroke and poor functional outcome. Similar results were observed for the outcomes of composite vascular events, ischemic stroke and all-cause mortality. CONCLUSIONS: Elevated baseline serum FFA level was associated with an increased risk of new stroke, as well as composite vascular events, ischemic stroke, and poor functional outcome at 3-month follow-up in patients with acute ischemic stroke.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.